rs28763878
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000090.4(COL3A1):c.2661+22T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0337 in 1,613,042 control chromosomes in the GnomAD database, including 1,109 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.023 ( 44 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1065 hom. )
Consequence
COL3A1
NM_000090.4 intron
NM_000090.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.06
Genes affected
COL3A1 (HGNC:2201): (collagen type III alpha 1 chain) This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 2-189003809-T-A is Benign according to our data. Variant chr2-189003809-T-A is described in ClinVar as [Benign]. Clinvar id is 254965.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-189003809-T-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0227 (3462/152304) while in subpopulation NFE AF = 0.0371 (2522/68022). AF 95% confidence interval is 0.0359. There are 44 homozygotes in GnomAd4. There are 1592 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 44 AD,AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL3A1 | ENST00000304636.9 | c.2661+22T>A | intron_variant | Intron 38 of 50 | 1 | NM_000090.4 | ENSP00000304408.4 | |||
COL3A1 | ENST00000450867.2 | c.2562+22T>A | intron_variant | Intron 37 of 49 | 1 | ENSP00000415346.2 | ||||
COL3A1 | ENST00000467886.1 | n.118T>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0227 AC: 3462AN: 152186Hom.: 44 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3462
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0234 AC: 5888AN: 251344 AF XY: 0.0233 show subpopulations
GnomAD2 exomes
AF:
AC:
5888
AN:
251344
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0348 AC: 50883AN: 1460738Hom.: 1065 Cov.: 31 AF XY: 0.0339 AC XY: 24658AN XY: 726796 show subpopulations
GnomAD4 exome
AF:
AC:
50883
AN:
1460738
Hom.:
Cov.:
31
AF XY:
AC XY:
24658
AN XY:
726796
Gnomad4 AFR exome
AF:
AC:
197
AN:
33460
Gnomad4 AMR exome
AF:
AC:
596
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
359
AN:
26126
Gnomad4 EAS exome
AF:
AC:
2
AN:
39692
Gnomad4 SAS exome
AF:
AC:
1020
AN:
86234
Gnomad4 FIN exome
AF:
AC:
928
AN:
53406
Gnomad4 NFE exome
AF:
AC:
45972
AN:
1110972
Gnomad4 Remaining exome
AF:
AC:
1780
AN:
60356
Heterozygous variant carriers
0
2335
4669
7004
9338
11673
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1706
3412
5118
6824
8530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0227 AC: 3462AN: 152304Hom.: 44 Cov.: 32 AF XY: 0.0214 AC XY: 1592AN XY: 74476 show subpopulations
GnomAD4 genome
AF:
AC:
3462
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
1592
AN XY:
74476
Gnomad4 AFR
AF:
AC:
0.00731473
AN:
0.00731473
Gnomad4 AMR
AF:
AC:
0.0193464
AN:
0.0193464
Gnomad4 ASJ
AF:
AC:
0.0100806
AN:
0.0100806
Gnomad4 EAS
AF:
AC:
0.000577812
AN:
0.000577812
Gnomad4 SAS
AF:
AC:
0.0120133
AN:
0.0120133
Gnomad4 FIN
AF:
AC:
0.0162081
AN:
0.0162081
Gnomad4 NFE
AF:
AC:
0.0370762
AN:
0.0370762
Gnomad4 OTH
AF:
AC:
0.0250947
AN:
0.0250947
Heterozygous variant carriers
0
179
358
536
715
894
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=98/2
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
Splicevardb
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at